Ineffective motility is not a marker for gastroesophageal reflux disease

American Journal of Gastroenterology

Volumn 98, Issue 4, 2003, Pages 771-776

  Vinjirayer, Elango ^a   Gonzalez, Begona ^a   Brensinger, Colleen ^a   Bracy, Nicole ^a   Obelmejias, Robin ^a   Katzka, David A ^a   Metz, David C ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b Division of Gastroenterology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTACID AGENT;

ADULT; ARTICLE; BIOLOGICAL MONITORING; DATA BASE; ESOPHAGUS MOTILITY; FEMALE; GASTROESOPHAGEAL REFLUX; HUMAN; LABORATORY; MAJOR CLINICAL STUDY; MALE; MANOMETRY; PERISTALSIS; PH MEASUREMENT; PREVALENCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; REVIEW; STOMACH ACID; SYMPTOM;

EID: 0037508914     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2003.07391.x     Document Type: Article

References (42)

1. Alrakawi A, Clouse RE. The changing use of esophageal manometry in clinical practice. Am J Gastroenterol 1998;93: 2359-62.
2. Richter JE. Gastroesophageal reflux disease as a cause of chest pain. Med Clin North Am 1991;75:1065-80.
3. Szarka LA, DeVault KR, Murray JA. Diagnosing gastroesophageal reflux disease. Mayo Clin Proc 2001;76:97-101.
4. Richter JE. Severe reflux esophagitis. Gastrointest Endosc Clin N Am 1994;4:677-98.
5. Richter JE. Gastroesophageal reflux disease in the older patient: Presentation, treatment, and complications. Am J Gastroenterol 2000;95:368-73.
6. Dent J, Holloway RH, Toouli J, et al. Mechanisms of lower oesophageal sphincter incompetence in patients with symptomatic gastrooesophageal reflux. Gut 1988;29:1020-8.
7. Katzka DA, Sidhu M, Castell DO. Hypertensive lower esophageal sphincter pressures and gastroesophageal reflux: An apparent paradox that is not unusual. Am J Gastroenterol 1995;90:280-4.
8. Trifan A, Shaker R, Ren J, et al. Inhibition of resting lower esophageal sphincter pressure by pharyngeal water stimulation in humans. Gastroenterology 1995;108:441-6.
9. Holloway RH, Kocyan P, Dent J. Provocation of transient lower esophageal sphincter relaxations by meals in patients with symptomatic gastroesophageal reflux. Dig Dis Sci 1991; 36:1034-9.
10. Mittal RK, Holloway RH, Penagini R, et al. Transient lower esophageal sphincter relaxation. Gastroenterology 1995;109: 601-10.
11. Mattox HE 3rd, Richter JE, Sinclair JW, et al. Gastroesophageal pH step-up inaccurately locates proximal border of lower esophageal sphincter. Dig Dis Sci 1992;37:1185-91.
12. Winters C Jr, Spurling TJ, Chobanian SJ, et al. Barrett's esophagus. A prevalent, occult complication of gastroesophageal reflux disease. Gastroenterology 1987;92:118-24.
13. Leite LP, Johnston BT, Barrett J, et al. Ineffective esophageal motility (IEM): The primary finding in patients with nonspecific esophageal motility disorder. Dig Dis Sci 1997;42:1859-65.
14. Fouad YM, Katz PO, Hatlebakk JG, et al. Ineffective esophageal motility: The most common motility abnormality in patients with GERD-associated respiratory symptoms. Am J Gastroenterol 1999;94:1464-7.
15. Diener U, Patti MG, Molena D, et al. Esophageal dysmotility and gastroesophageal reflux disease. J Gastrointest Surg 2001; 5:260-5.
16. McKernan JB. Laparoscopic repair of gastroesophageal reflux disease. Toupet partial fundoplication versus Nissen fundoplication. Surg Endosc 1994;8:851-6.
17. Katzka DA. Motility abnormalities in gastroesophageal reflux disease. Gastroenterol Clin North Am 1999;28:905-15.
18. Swanstrom LL. Partial fundoplications for gastroesophageal reflux disease: Indications and current status. J Clin Gastroenterol 1999;29:127-32.
19. Laws HL, Clements RH, Swillie CM. A randomized, prospective comparison of the Nissen fundoplication versus the Toupet fundoplication for gastroesophageal reflux disease. Ann Surg 1997;225:647-53, discussion 654.
20. Wills VL, Hunt DR. Dysphagia after antireflux surgery. Br J Surg 2001;88:486-99.
21. Bessell JR, Finch R, Gotley DC, et al. Chronic dysphagia following laparoscopic fundoplication. Br J Surg 2000;87: 134-5.
22. Rydberg L, Ruth M, Abrahamsson H, et al. Tailoring antireflux surgery: A randomized clinical trial. Br J Surg 2000;87: 1341-5.
23. Baigrie RJ, Watson DI, Myers JC, et al. Outcome of laparoscopic Nissen fundoplication in patients with disordered preoperative peristalsis. Gut 1997;40:381-5.
24. Fuller L, Huprich JE, Theisen J, et al. Abnormal esophageal body function: Radiographic-manometric correlation. Am Surg 1999;65:911-4.
25. Bennett JR. pH measurement in the oesophagus. Baillieres Clin Gastroenterol 1987;1:747-67.
26. de Caestecker JS, Heading RC. Esophageal pH monitoring. Gastroenterol Clin North Am 1990;19:645-69.
27. Wo JM, Castell DO. Exclusion of meal periods from ambulatory 24-hour pH monitoring may improve diagnosis of esophageal acid reflux. Dig Dis Sci 1994;39:1601-7.
28. Dobman R, Castell DO. Normal and abnormal proximal esophageal acid exposure: Results of ambulatory dual probe pH monitoring. Am J Gastroenterol 1993;88:25-9.
29. Johnson LF, DeMeester TR. Twenty-four-hour pH monitoring of the distal esophagus. Am J Gastroenterol 1974;62:323.
30. Kuo B, Castell DO. Optimal dosing of omeprazole 40 mg daily: Effects on gastric and esophageal pH and serum gastrin in healthy controls. Am J Gastroenterol 1996;91:1532-8.
31. Castell JA, Gideon RM, Castell DO. Esophagus. In: Schuster MM, ed. Atlas of GI motility in health and disease, 1st ed. Baltimore, MD: Williams & Wilkins, 1993:134-57.
32. Dalton CB, Castell JA. The manometric study. In: Castell DO, Castell JA, eds. Esophageal motility testing, 2nd ed. Norwalk, CT: Appleton & Lange, 1994:35-61.
33. Richter JE, Castell DO. Diffuse esophageal spasm: A reap-praisal. Ann Intern Med 1984;100:242-5.
34. DiBaise JK, Lof J, Quigley EM. Can symptoms predict esophageal motor function or acid exposure in gastroesophageal reflux disease? A comparison of esophageal manometric and twenty-four-hour pH parameters in typical and extraesophageal gastroesophageal reflux disease. J Clin Gastroenterol 2001;32:128-32.
35. Knight RE, Wells JR, Parrish RS. Esophageal dysmotility as an important co-factor in extraesophageal manifestations of gastroesophageal reflux. Laryngoscope 2000;110:1462-6.
36. Tuttle SG, Rufin F, Bettarello A. The physiology of heartburn. Ann Intern Med 1961;55:292-300.
37. Wiener GJ, Morgan TM, Copper JB, et al. Ambulatory 24-hour esophageal pH monitoring. Reproducibility and variability of pH parameters. Dig Dis Sci 1988;33:1127-33.
38. Wiener GJ, Richter JE, Copper JB, et al. The symptom index: A clinically important parameter of ambulatory 24-hour esophageal pH monitoring. Am J Gastroenterol 1988;83:358-61.
39. Al-Sabbagh G, Wo JM. Supraesophageal manifestations of gastroesophageal reflux disease. Semin Gastrointest Dis 1999; 10:113-9.
40. Breumelhof R, Smout AJ. The symptom sensitivity index: A valuable additional parameter in 24-hour esophageal pH recording. Am J Gastroenterol 1991;86:160-4.
41. Kahrilas PJ, Dodds WJ, Hogan WJ. Effect of peristaltic dysfunction on esophageal volume clearance. Gastroenterology 1988;94:73-80.
42. Kahrilas PJ. Esophageal motor activity and acid clearance. Gastroenterol Clin North Am 1990;19:537-50.